. lnfrasondeR (Sphyngometrics), a small, lightweight (6.2 lbs) battery-powered, indirect blood pressure system was tested unde a variety of clinical conditions in neonates. This system consists of a passive transducer (1x1 cm) placed under a disposabl cuff which electronically senses arterial wall oscillations on narrow subaudible (infrasonic) frequency band thereby improving accuracy by increasing the signal to noise ratio.
EVALUATION OF A NEW INDIRECT BLOOD PRESSURE SYSTEM FOR NEONATES. Leonard L. Fox, Dale L. Phelps, (Spon by Cynthia T. Barrett), UCLA School of Medicine. Dept. of Pediatrics, Los Angeles, California. lnfrasondeR (Sphyngometrics), a small, lightweight (6.2 lbs) battery-powered, indirect blood pressure system was tested unde a variety of clinical conditions in neonates. This system consists of a passive transducer (1x1 cm) placed under a disposabl cuff which electronically senses arterial wall oscillations on narrow subaudible (infrasonic) frequency band thereby improving accuracy by increasing the signal to noise ratio.
Ten neonates (1360 to 4500 gms), catheterized for medical reasons (RDS, shock, sepsis), were studied. Approximately 20 readings each by experienced and inexperienced personnel were made on the right arm, left arm, and one leg, simultaneously re cording the direct transducer pressure from an arterial cathete attached to a KDC monitor at the exact moment that the Infrasonde reading was taken. Comparing absolute differences betwee the Infrasonde and the direct arterial pressure over a wide range (diastolic 18 to 60 mm Hg, systolic 38 to 105 mm Hg), we were unable to detect any difference between experienced and in experienced personnel, right and left arms, and arms and legs; therefore all the readings were combined. The correlation coefficient between direct arterial and Infrasonde pressures was r=.900, n-113 diastolic and r=.940, n=113 systolic.
These data indicate that Infrasonde correlates well with direct arterial pressures and could be especially useful when there is no indwelling catheter uresent. Intralipid is widely used for parenteral nutrition of infants with respiratory distress but hypoxemia has been reported in adults receiving IV intralipid infusions. To determine changes i pulmonary function during a 4 hr. intralipid infusion, 1 gm/kg intralipid was administered to 7 small premature neonates with mean wt. 1.16 kg (range 0.88-1.50) and mean gest. age 29 weeks. Arterial blood gases, func. resid. cap. (FRC), tidal volume (TV) resp. rate (RR), lung compliance (CL) and insp. (RI) and exp. (RE) pulmonary resistance, serum triglycerides (TG) and free fat ty acids (FFA) were determined at control (pre-infusion), at 4 hours and at followup (4 hours after infusion). Control (mean + SEM) FFA (0.58 + .17) and TG (54.1 + 6.3) increased at 4 hours 2.0 + 0.37 and 230.0 + 66.2. Control PO2 (66.4 + 11.1) decrease( post infusion to 54.1 + 2.1 mm Hg. At followup, both mean FFA and TG were higher than control values and less than post infusion. Mean + SEM followup PO2 (62.6 + 6.4) was higher than post infusion but lower than conrrols. There were no significant differences in pC02, pH, base excess, RR, VT, min. vent., CL, RI RE, or FRC for all 3 parts of the study. This study indicates that intralipid infusion in premature neonates affects PO2 but ioes not cause quantitative changes in other blood gas parameter or pulmonary function.
EFFECTS OF INTRALIPID
Taeusch, Jr., Dept. of Pediatrics and Radiology, '~arvard Medical School, Boston, MA. In an attempt to correlate the thymolytic effect of glucocorticoids with their role in the induction of surfactant synthesis and the prevention of RDS, the size of the thymus on the initial chest radiographs of newborns who required intensive care was re viewed. Utilizing a ratio of the cardiothymic silhouette at the carina to the thoracic width (C-T/T) we found an increase in C-T/T with increasing gestational age. Newborn infants with RDS had a significantly elevated mean C-T/T (0.40 vs 0.76; p <0.001 an increased percentage of 'enlarged' (C-T/T > 0.45) thvmuses (?8% vs 8% in non-RDS babies), and a decreased percentage of *smallv (C-T/T * 0.30) thymuses (11% vs. 26%). Moreover, in a series of 8 multiple gestations that were discordant for RDS, th larger thymus was seen in those with RDS in 6 of 8, while in on1 one did the converse hold true.Surprjsingly,babies whose mother had received prepartum dexamethasone to prevent RDS showed no difference in thymic size when compared to a control population. These data are consistent with the theory that endogenous glucocorticoids play a physiologic role in the prevention of RDS. The initial size of the thymus may also be of predictive value in differentiating between the diverse causes of respiratory distress in newborn infants. There were no significant differences between the groups in the level of serum sodium, osmolality, inbornloutborn ratio and age of admission to NICU.
BICARBONATE (B) AND IPlTRACRAllIAL IIIIIOPXHAGE (ICH) IN

HYALINE MDlBFUNE DISUSE (HID
We conclude that a direct relationship exists between ICH, perinatal asphyxia and prematurity. No correlation was found between B administration and ICH. ----istered to fetal rabbits is reported to increase pulmonary surfactant content. To explore these relationships we have measured PRL in umbilical cord sera from 78 infants of gestational age 28 to 40 weeks. A positive relationship to gestational age was demonstrated. Between 30 and 36 weeks gestation, analysis of covari. ance of PRL versus gestational age showed that infants who did not develop RDS had significantly higher cord PRL concentrations (p<0.05) than infants who developed RDS. Between 32 and 35.5 weeks the mean + SEM cord PRL of normal infants (161.8t18.9 ngl ml) is higher (p<0.025) than in those who developed RDS (101.7t 9.5 nglrnl). Growth hormone concentrations in the same samples dil not show any relationship to the incidence of RDS. Cord PRL did not correlate with cord F or dehydroepiandrosterone sulphate (DHEAS) concentration. Serum PRL was not suppressed in a second group of 114 infants whose mothers were treated prenatally with betamethasone, but F and DHEAS were. The finding of low cord PRI in infants who develop RDS is consistent with the possibility that PRL may influence fetal lung maturation.
To exclude the possibility that this potential association is due to a postulated adrenocorticotropic effect of PRL, we infuse ovine PRL (I mg/day) into fetal sheep for periods of 6 to 8 days in late gestation. No effect on F, DHEAS, or F binding capacity Pneumopericardium (PPC) developed i n 16 o f 873 ( 2 % ) neonates r e c e i v i n g a s s i s t e d v e n t i l a t i o n ; 14 were prematures w i t h RDS r eq u i r i n g a s s i s t e d v e n t i l a t i o n w i t h i n 12 hours. Pneumothorax (PNX) developed c o i n c i d e n t a l l y i n a l l b u t one. P e r i c a r d i o c e n t e s i s (PCX was performed i n 11 o f whom 7 (42%) survived. Cardiovascular parameters of h e a r t r a t e (HR), a r t e r i a l blood pressure (ABP), c e n t r a l venous pressure (CVP) and ECG were measured d u r i n g 10 episodes o f PPC. E a r l y evidence o f c a r d i a c tamponade (CT) was moderate tachycardia and a sharp r i s e i n CVP. T h i s was f o l l o w e d by bradycardia and an a b r u p t decrease i n p u l s e and ABP. Marked S' segment depression w i t h AV d i s s o c i a t i o n and 2' h e a r t b l o c k were noted a t t h i s time. F o l l o w i n g PCX, a rebound tachycardia, wideni n g o f p u l s e pressure, r e t u r n o f ABP t o b a s e l i n e and a gradual f a l l i n CVP occurred i n s u r v i v o r s w h i l e i n those who died, brady c a r d i a and hypotension p e r s i s t e d . PPC as a c o m p l i c a t i o n o f a s s i s t e d v e n t i l a t i o n should be expected i n a small number o f i n f a n t s ~i t h RDS. I f t h e i n f a n t develoos a oneumothorax, t h i s r i s k i s i g n i f i c a n t l y increased. he d i a g n o i i s can be made b e f c r e death y c a r d i o v a s c u l a r changes described. The c o n d i t i o n can be suce s s f u l l y t r e a t e d and adequacy of treatment can be assessed by he same f a c t o r s used f o r diagnosis.
